The Day Pharma’s Weight-Loss Gold Rush Intensified
Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion anti-obesity market is among pharma’s hottest.
Source link
Get latast news super fast
